SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lisette Bazán-Rodríguez, Amin Cervantes-Arriaga, Rodrigo Llorens-Arenas, Humberto Calderón-Fajardo, Mayela Rodríguez-Violante, No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease, Movement Disorders Clinical Practice, 2016, 3, 1
  2. 2
    Mutsumi Iijima, Mikio Osawa, Kenji Maruyama, Shinichiro Uchiyama, Kazuo Kitagawa, Self-Reported Adherence after Overnight Switching from Immediate- to Extended-Release Pramipexole in Parkinson’s Disease, Advances in Parkinson's Disease, 2015, 04, 01, 13

    CrossRef

  3. 3
    Fabio Blandini, Marie-Therese Armentero, Dopamine receptor agonists for Parkinson's disease, Expert Opinion on Investigational Drugs, 2014, 23, 3, 387

    CrossRef

  4. 4
    Matthias Löhle, Carl-Johan Ramberg, Heinz Reichmann, Anthony H. V. Schapira, Early Versus Delayed Initiation of Pharmacotherapy in Parkinson’s Disease, Drugs, 2014, 74, 6, 645

    CrossRef

  5. 5
    R. A. Hauser, A. H. V. Schapira, P. Barone, Y. Mizuno, O. Rascol, M. Busse, C. Debieuvre, M. Fraessdorf, W. Poewe, Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease, European Journal of Neurology, 2014, 21, 5
  6. 6
    James E. Frampton, Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease, Drugs, 2014, 74, 18, 2175

    CrossRef

  7. 7
    A. H. V. Schapira, Recent advances in neurology 2013–2014, European Journal of Neurology, 2014, 21, 12
  8. 8
    Juan C. Giugni, Michael S. Okun, Treatment of advanced Parkinsonʼs disease, Current Opinion in Neurology, 2014, 27, 4, 450

    CrossRef

  9. 9
    E. C. H. Lim, Dosing issues in Parkinson's disease – patient preferences and their influence on compliance, European Journal of Neurology, 2013, 20, 1
  10. 10
    Robert A Hauser, Ann Hsu, Sherron Kell, Alberto J Espay, Kapil Sethi, Mark Stacy, William Ondo, Martin O'Connell, Suneel Gupta, Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial, The Lancet Neurology, 2013, 12, 4, 346

    CrossRef

  11. 11
    Scott Kaplan, Daniel Tarsy, Initial Treatment of Parkinson’s Disease: An Update, Current Treatment Options in Neurology, 2013, 15, 4, 377

    CrossRef

  12. 12
    A. H. V. Schapira, E. K. Tan, Optimizing treatment for Parkinson's disease, European Journal of Neurology, 2012, 19, 12